Your browser doesn't support javascript.
loading
Recent advances in functionalized upconversion nanoparticles for light-activated tumor therapy.
Chu, Hongqian; Cao, Tingming; Dai, Guangming; Liu, Bei; Duan, Huijuan; Kong, Chengcheng; Tian, Na; Hou, Dailun; Sun, Zhaogang.
Affiliation
  • Chu H; Translational Medicine Center, Beijing Chest Hospital, Capital Medical University Beijing 101149 PR China sunzhaogang@bjxkyy.cn.
  • Cao T; Beijing Key Laboratory in Drug Resistant Tuberculosis Research, Beijing Tuberculosis and Thoracic Tumor Research Institute Beijing 101149 PR China.
  • Dai G; Translational Medicine Center, Beijing Chest Hospital, Capital Medical University Beijing 101149 PR China sunzhaogang@bjxkyy.cn.
  • Liu B; Beijing Key Laboratory in Drug Resistant Tuberculosis Research, Beijing Tuberculosis and Thoracic Tumor Research Institute Beijing 101149 PR China.
  • Duan H; Translational Medicine Center, Beijing Chest Hospital, Capital Medical University Beijing 101149 PR China sunzhaogang@bjxkyy.cn.
  • Kong C; Beijing Key Laboratory in Drug Resistant Tuberculosis Research, Beijing Tuberculosis and Thoracic Tumor Research Institute Beijing 101149 PR China.
  • Tian N; School of Science, Minzu University of China Beijing 100081 PR China.
  • Hou D; Translational Medicine Center, Beijing Chest Hospital, Capital Medical University Beijing 101149 PR China sunzhaogang@bjxkyy.cn.
  • Sun Z; Beijing Key Laboratory in Drug Resistant Tuberculosis Research, Beijing Tuberculosis and Thoracic Tumor Research Institute Beijing 101149 PR China.
RSC Adv ; 11(56): 35472-35488, 2021 Oct 28.
Article in En | MEDLINE | ID: mdl-35493151